Featured News Image Research news | Feb 23 2026 Knight Initiative for Brain Resilience Engineered immune therapy could help fight brain aging Neuroscientists studying inflammation and age-related brain decline engineered a protein that spurs the growth of new neurons in aging mice Image Research news | Feb 19 2026 Wu Tsai Neurosciences Institute Why the brain misunderstands speech after stroke In stroke patients with aphasia, the brain spends too little time processing ambiguous sounds, researchers find, suggesting new targets for precision therapies Image Wu Tsai Neuro News | Feb 18 2026 Stanford Report Three Wu Tsai Neuro scientists are named Sloan Research Fellows Faculty Scholar Guosong Hong and institute affiliates Christoph Thaiss and Steven Banik were among eight Stanford researchers to receive the honor Image Knight Initiative news | Feb 12 2026 Knight Initiative for Brain Resilience Preventing Parkinson’s, a new Alzheimer’s drug, and more featured at tenth Knigh... Researchers from around the world convened at Stanford to present their latest work on neurodegeneration and brain resilience News Filter & Sort Sort by ThemeNeuroHealth NeuroEngineering News TypeResearch news Researcher profiles Podcast episodes Sort by Newest to oldest Oldest to newest Image Podcast episodes | Mar 14 2024 Wu Tsai Neurosciences Institute Mind Traveler This week, I join my producer Michael Osborne on his podcast, Famous and Gravy, to discuss the late, great neuroscientist and author Oliver Sacks. Image Researcher profiles | Jul 12 2023 Wu Tsai Neurosciences Institute Q&A: Using software engineering to bring back speech in ALS Erin Kunz, third year PhD student in Electrical Engineering, started her career developing autonomous vehicles at General Motors (GM) — but now she uses her software engineering and machine learning skills in the Neural Prosthetics Translational Lab. Image Research news | Feb 23 2022 Wu Tsai Neurosciences Institute Researchers connect ALS hallmark to gene Wu Tsai Neuro researchers have linked a specific gene known to be associated with ALS with a characteristic of the disease, opening avenues for a targeted therapy.
Image Research news | Feb 23 2026 Knight Initiative for Brain Resilience Engineered immune therapy could help fight brain aging Neuroscientists studying inflammation and age-related brain decline engineered a protein that spurs the growth of new neurons in aging mice
Image Research news | Feb 19 2026 Wu Tsai Neurosciences Institute Why the brain misunderstands speech after stroke In stroke patients with aphasia, the brain spends too little time processing ambiguous sounds, researchers find, suggesting new targets for precision therapies
Image Wu Tsai Neuro News | Feb 18 2026 Stanford Report Three Wu Tsai Neuro scientists are named Sloan Research Fellows Faculty Scholar Guosong Hong and institute affiliates Christoph Thaiss and Steven Banik were among eight Stanford researchers to receive the honor
Image Knight Initiative news | Feb 12 2026 Knight Initiative for Brain Resilience Preventing Parkinson’s, a new Alzheimer’s drug, and more featured at tenth Knigh... Researchers from around the world convened at Stanford to present their latest work on neurodegeneration and brain resilience
Image Podcast episodes | Mar 14 2024 Wu Tsai Neurosciences Institute Mind Traveler This week, I join my producer Michael Osborne on his podcast, Famous and Gravy, to discuss the late, great neuroscientist and author Oliver Sacks.
Image Researcher profiles | Jul 12 2023 Wu Tsai Neurosciences Institute Q&A: Using software engineering to bring back speech in ALS Erin Kunz, third year PhD student in Electrical Engineering, started her career developing autonomous vehicles at General Motors (GM) — but now she uses her software engineering and machine learning skills in the Neural Prosthetics Translational Lab.
Image Research news | Feb 23 2022 Wu Tsai Neurosciences Institute Researchers connect ALS hallmark to gene Wu Tsai Neuro researchers have linked a specific gene known to be associated with ALS with a characteristic of the disease, opening avenues for a targeted therapy.
